发明名称 Methods and compositions for treating dry eye disease and other eye disorders
摘要 The present invention discloses pharmaceutical preparations for treatment of eye disorders containing an alpha 2 adrenergic agonist, to processes for producing the pharmaceutical preparations and methods for treatment of various eye disorders including dry eye and Meibomian gland dysfunction and a medicinal applicator for topical application of an alpha 2 adrenergic agonist to a subject, a package assembly for the medicinal applicator and methods of using the medicinal applicator to treat eye disorders.
申请公布号 US9597328(B2) 申请公布日期 2017.03.21
申请号 US201615051654 申请日期 2016.02.23
申请人 Ocugen, Inc.;The Board of Trustees of the University of Illinois 发明人 Jain Sandeep;Kompella Uday Bhaskar;Musunuri Shankar
分类号 A61K9/14;A61K31/498;A61K31/573;A61K9/00;A61K9/107;A61K9/06;A61K47/32;A61K47/36;A61K47/38;A61K9/08 主分类号 A61K9/14
代理机构 Hamilton DeSanctis & Cha, LLP. 代理人 Cha Don D.;Hamilton DeSanctis & Cha, LLP.
主权项 1. A method of treating a patient suffering from a dry eye syndrome comprising administering to an eye of the patient in need of such a treatment an ophthalmological pharmaceutical formulation comprising nanoemulsion of oil, a therapeutically effective amount of an active ingredient for treating a dry eye syndrome, wherein said active ingredient consists of an alpha 2 adrenergic agonist having a higher alpha 2A agonist activity compared to alpha 2B agonist activity or a pharmaceutically acceptable salt thereof.
地址 Malvern PA US